Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial.
Journal: Nature medicine
Published: March 31, 2022
Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 06, 2019
Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients.
Journal: Molecular pharmaceutics
Published: May 24, 2019
Time-to-Event Modeling of Peripheral Neuropathy: Platform Analysis of Eight Valine-Citrulline-Monomethylauristatin E Antibody-Drug Conjugates.
Journal: CPT: pharmacometrics & systems pharmacology
Published: February 20, 2019
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo properties.
Journal: mAbs
Published: December 15, 2018
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 06, 2018
Platform model describing pharmacokinetic properties of vc-MMAE antibody-drug conjugates.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: June 12, 2017
Peripheral neuropathy with microtubule inhibitor containing antibody drug conjugates: Challenges and perspectives in translatability from nonclinical toxicology studies to the clinic.
Journal: Regulatory toxicology and pharmacology : RTP
Published: August 12, 2016
ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 29, 2015
Pertuzumab and erlotinib in patients with relapsed non-small cell lung cancer: a phase II study using 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging.
Journal: The oncologist
Published: January 25, 2014
Last Updated: 09/26/2026